Clinical Presentation and Outcome of Critically Ill Patients with Inflammatory Bowel Disease.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 75, doi. 10.1159/000537885
- By:
- Publication type:
- Article
Works matching IS 22974725 AND DT 2024 AND VI 40 AND IP 2
Results: 8
1
2
Front & Back Matter.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 1, doi. 10.1159/000538672
- Publication type:
- Article
3
PharmaNews.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 102, doi. 10.1159/000538473
- Publication type:
- Article
4
Society Bulletins.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 104, doi. 10.1159/000538357
- Publication type:
- Article
5
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 53, doi. 10.1159/000537884
- By:
- Publication type:
- Article
6
Microbiota Therapy in Inflammatory Bowel Disease.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 92, doi. 10.1159/000536254
- By:
- Publication type:
- Article
7
Usage Behaviour and Adoption Criteria for Mobile Health Solutions in Patients with Chronic Diseases in Gastroenterology.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 61, doi. 10.1159/000534191
- By:
- Publication type:
- Article
8
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 2, p. 82, doi. 10.1159/000535851
- By:
- Publication type:
- Article